Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-08-13

FDA Approved: RILUZOLE — Supplemental Application (Ascend Laboratories, LLC)

View source ↗

Summary

FDA approved a supplemental application for riluzole submitted by Ascend Laboratories, LLC, updating the approved riluzole product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Riluzole (riluzole)

Snippet

SUPPL AP for RILUZOLE (RILUZOLE)